XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Public Offering
At-the-Market Offering
Common Stock
Common Stock
Public Offering
Common Stock
At-the-Market Offering
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-In Capital
Public Offering
Additional Paid-In Capital
At-the-Market Offering
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2018 $ 126,714       $ 4     $ 322,993       $ (196,170)   $ (113)
Balance, shares at Dec. 31, 2018         38,834,000                  
Issuance of common stock     $ 53,761 $ 43,968   $ 1 $ 1     $ 53,760 $ 43,967      
Issuance of common stock, shares           14,375,000 9,929,000              
Issuance of common stock pursuant to equity incentive plans 1,222             1,222            
Issuance of common stock pursuant to equity incentive plans, shares         376,000                  
Stock-based compensation expense 6,466             6,466            
Cumulative-effect adjustment from adoption of accounting standard | ASC 2018-07                 $ 71       $ (71)  
Net loss (89,860)                     (89,860)    
Unrealized gain (loss) on available-for-sale securities 155                         155
Balance at Dec. 31, 2019 142,426       $ 6     428,479       (286,101)   42
Balance, shares at Dec. 31, 2019         63,514,000                  
Issuance of common stock     $ 33,464 7,397   $ 1       $ 33,463 7,397      
Issuance of common stock, shares           5,750,000 1,160,000              
Issuance of common stock pursuant to equity incentive plans 1,200             1,200            
Issuance of common stock pursuant to equity incentive plans, shares         262,000                  
Stock-based compensation expense 8,060             8,060            
Net loss (90,137)                     (90,137)    
Unrealized gain (loss) on available-for-sale securities (39)                         (39)
Balance at Dec. 31, 2020 $ 102,371       $ 7     478,599       (376,238)   3
Balance, shares at Dec. 31, 2020         70,686,000                  
Temporary equity, Balance, shares at Dec. 31, 2020 0                          
Issuance of series A convertible preferred stock, net of issuance costs of $173   $ 40,702                        
Issuance of series A convertible preferred stock, net of issuance costs of $173, shares   1,000,000                        
Issuance of common stock       $ 10,661     $ 1       $ 10,660      
Issuance of common stock, shares             5,245,000              
Issuance of common stock pursuant to equity incentive plans $ 177             177            
Issuance of common stock pursuant to equity incentive plans, shares         1,213,000                  
Stock-based compensation expense 10,264             10,264            
Net loss (115,088)                     (115,088)    
Unrealized gain (loss) on available-for-sale securities (3)                         $ (3)
Balance at Dec. 31, 2021 8,382       $ 8     $ 499,700       $ (491,326)    
Balance, shares at Dec. 31, 2021         77,144,000                  
Temporary equity, Balance at Dec. 31, 2021 $ 40,702 $ 40,702                        
Temporary equity, Balance, shares at Dec. 31, 2021 1,000,000 1,000,000